CellMark and its CEO lacked scientific evidence to back up their products’ claims
CellMark Biopharma, LLC and its CEO have agreed to settle Federal Trade Commission charges that they made false or unsupported claims regarding two health products they marketed as effective treatments for cancer patients’ malnutrition and “chemo fog,” or treatment-related cognitive dysfunction
FTC Warns Operators of Websites that Charge for an Employer Identification Number and Claim Affiliation with the IRS